Taiwanese chemical industry news

• 

  2 April 2026

  FDA approves Lilly's Foundayo (orforglipron), oral GLP‑1 for anytime dosing

  Oral GLP‑1 produced ~12% mean weight loss (~27 lb) at 72 weeks in Phase 3. Available via direct home delivery with low‑cost copays; carries thyroid tumor and GI side‑effect warnings.
• 

  31 March 2026

  Mitsubishi Chemical transfers KMC MMA monomer stake in Taiwan to CPDC

  Dissolve co-ownership of Taiwan MMA unit amid stronger Asian competition and Chinese capacity growth; consolidate production to competitive sites and pursue high-growth markets. Completion Aug 3, 2026.
• 

  25 March 2026

  Air Liquide opens first Advanced Materials plant in Taiwan

  New Taichung plant will make advanced deposition and etch materials (ALD) for next‑gen AI/HPC chips, localizing supply, boosting collaboration and high‑volume ramp; €1B+ invested in Taiwan since 2019.
• 

  25 March 2026

  Novo Nordisk: UBT251 reduced HbA1c up to 2.16% at 24 weeks in Chinese Phase 2 T2D trial

  Triple-agonist UBT251 (GLP-1/GIP/glucagon) induced up to 9.8% weight loss, improved BP and lipids vs placebo/semaglutide. Safety consistent with triple-G class; global phase-2 and China phase-3 planned
• 

  23 March 2026

  GSK’s risvutatug rezetecan granted orphan drug designation for SCLC in Japan

  Risvutatug rezetecan, a B7-H3–targeted ADC, showed durable responses in extensive‑stage SCLC in phase I ARTEMIS‑001; global phase III in relapsed ES‑SCLC is underway.
• 

  18 March 2026

  Taiwan Bio and Terumo BCT to automate Treg manufacturing on Quantum Flex

  Evaluate a 3-in-1 workflow to stabilize and scale Treg production for TRK-001 Phase 2, cut variability and COGS, shorten cycle time, and enable next-gen engineered Treg INDs.

• 

  3 March 2026

  GSK Finalizes RAPT Therapeutics Acquisition

  GSK acquires ozureprubart, a potential long-acting anti-IgE therapy for food allergies, with phase IIb data expected in 2027. The deal is valued at $2.2 billion.
• 

  6 February 2026

  Ørsted Reports DKK 25.1 Billion Earnings in 2025

  Ørsted strengthened its capital structure, completed divestments, and expanded offshore wind capacity, achieving a net profit of DKK 3.2 billion in 2025.
• 

  6 February 2026

  Sony Establishes First Global Supply Chain for Renewable Plastics in High-Performance Products

  Fourteen companies collaborate to create a supply chain for renewable plastics, enhancing Sony's product sustainability and tracking GHG emissions to reduce carbon footprint.
• 

  20 January 2026

  Ørsted Completes Wind Turbine Installation at Taiwan's Greater Changhua Offshore Farms

  The 920 MW Greater Changhua 2b and 4 offshore wind farms in Taiwan are now fully installed, marking a milestone in Asia-Pacific's offshore wind industry. Full operation expected by Q3 2026.
• 

  23 December 2025

  Ørsted Partners with Cathay for 55% Stake in Taiwan's Changhua 2 Wind Farm

  Cathay acquires 55% of Changhua 2 Wind Farm. Ørsted to provide long-term O&M. Transaction valued at DKK 5 billion, closing in Q3 2026. Strengthens Ørsted's capital structure.
• 

  11 December 2025

  Asahi Kasei Wins 2025 TSMC Performance Award

  Awarded for innovation in photosensitive dielectric for advanced packaging, Asahi Kasei emphasizes its focus on electronics and investment in semiconductor technology.
• 

  9 December 2025

  Asahi Kasei Wins 2025 TSMC Award for PIMEL™ in Advanced Packaging

  Award highlights innovation in Advanced Packaging materials, with focus on PIMEL™ and AI applications, as part of Asahi Kasei's strategic plan for 2025–2027.
• 

  6 October 2025

  INEOS to Close Two Rheinberg Plants Amid Rising Costs in Europe

  175 jobs lost due to high energy costs and lack of tariff protection. INEOS urges EU action to prevent further closures and maintain competitiveness.
• 

  30 September 2025

  BASF's SYNSPIRE G1-110 Catalyst Boosts Efficiency and Cuts Emissions at Nan Ya Plastics

  The SYNSPIRE G1-110 catalyst reduces steam use by 40,000 tons and CO2 emissions by 38,000 tons annually, enhancing sustainability in 2-EH production.
• 

  5 September 2025

  Ørsted Revises 2025 EBITDA Forecast

  Lower offshore wind speeds and project delays prompt EBITDA guidance adjustment to DKK 24-27 billion for 2025. Gross investment guidance remains at DKK 50-54 billion. Medium-term targets unaffected.
• 

  21 August 2025

  Covestro Names Annie Chen as Taiwan Managing Director

  Annie Chen, current Head of Supply Chain, will succeed Dr. Carsten Wildebrand as Managing Director in Taiwan, continuing to lead supply chain operations in Asia-Pacific.
• 

  10 July 2025

  Ørsted Secures Financing for Greater Changhua 2 Project

  Ørsted advances its strategic goals with project financing for Greater Changhua 2, supported by international banks and export credit agencies.